Three models were evaluated, presented as AUC (RTK, training cohort: 0.87, test cohort: 0.88; p53, training cohort: 0.80, test cohort: 0.76; retinoblastoma, training cohort: 0.84, test cohort: 0.81). Here, TP53 is linked to retinoblastoma.